PAHC Live signaler | Maksimer profitt med Getagraph.com

SELG 112258 min ago

@ $11.66

Utstedt: 14 feb 2024 @ 16:17

Avkastning: 42.52%

Forrige signal: feb 13 - 15:30

Forrige signal: Kjøp

Avkastning: -0.52 %

Live Chart Being Loaded With Signals

Commentary (2 mai 2024 @ 16:14):

Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for livestock primarily in the United States...

Stats
Dagens volum	13 672.00
Gjennomsnittsvolum	162 149
Markedsverdi	673.09M
EPS	$0 ( 2024-05-01 )
Neste inntjeningsdato	( $0.290 ) 2024-05-08
Last Dividend	$0.120 ( 2023-11-28 )
Next Dividend	$0 ( N/A )
P/E	44.91
ATR14	$0.0360 (0.22%)

Insider Trading

Date	Person	Action	Amount	type
2024-02-09	David Glenn	Buy	300 000	Restricted Stock Units
2024-02-09	David Glenn	Buy	0
2023-07-01	Weinstein Judith	Buy	0
2023-07-05	Miller Larry Lee	Buy	300 000	Restricted Stock Units
2023-02-06	Bernal Alejandro	Buy	0

INSIDER POWER
100.00
Last 94 transactions
Buy: 1 017 840 \| Sell: 862 050

Volum Korrelasjon

Lang: 0.00 (neutral)

Kort: 0.86 (strong)

Signal:(65.991) Same movement expected

Phibro Animal Health Corp Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Phibro Animal Health Corp Korrelasjon - Valuta/Råvare

-0.68
( moderate negative )

-0.83
( strong negative )

0.00
( neutral )

-0.51
( weak negative )

0.85
( strong )

0.82
( strong )

Phibro Animal Health Corp Økonomi

Annual	2023
Omsetning:	$977.89M
Bruttogevinst:	$298.24M (30.50 %)
EPS:	$0.810

FY	2023
Omsetning:	$977.89M
Bruttogevinst:	$298.24M (30.50 %)
EPS:	$0.810

FY	2022
Omsetning:	$942.30M
Bruttogevinst:	$285.40M (30.29 %)
EPS:	$1.210

FY	2021
Omsetning:	$833.35M
Bruttogevinst:	$271.38M (32.56 %)
EPS:	$1.340

Financial Reports:

No articles found.

Phibro Animal Health Corp Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0.120 (N/A)	$0.120 (N/A)	$0.120 (N/A)	$0.120 (N/A)	$0.120 (N/A)	$0.120 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Phibro Animal Health Corp Dividend Information - Dividend Knight

Dividend Sustainability Score: 7.62 - good (76.22%) | Divividend Growth Potential Score: 3.42 - Decrease likely (31.69%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.100	2014-08-29
Last Dividend	$0.120	2023-11-28
Next Dividend	$0	N/A
Payout Date	2023-12-20
Next Payout Date	N/A
# dividends	38	--
Total Paid Out	$4.22	--
Avg. Dividend % Per Year	1.85%	--
Score	4.27	--
Div. Sustainability Score	7.62
Div.Growth Potential Score	3.42
Div. Directional Score	5.52	--

Next Divdend (Est)
(2024-07-01)

$0.122 Estimate 39.46 %

Dividend Stability

0.79 Good

Dividend Score

4.27

Pay Frequency

Quarterly

Yearly Payout

Year	Amount	Yield
2014	$0.200	1.18%
2015	$0.400	1.30%
2016	$0.400	1.37%
2017	$0.400	1.35%
2018	$0.420	1.22%
2019	$0.480	1.50%
2020	$0.480	1.90%
2021	$0.480	2.44%
2022	$0.480	2.30%
2023	$0.480	3.51%
2024	$0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for NASDAQ

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
GLDI	Dividend Royal	2023-11-20	Monthly	12	7.15%	8.50
OXLC	Dividend Royal	2023-12-14	Monthly	14	10.00%	8.50
OXSQ	Dividend Diamond	2023-12-14	Monthly	21	9.10%	8.50
PSEC	Dividend Royal	2023-12-26	Monthly	21	7.04%	8.50
SLVO	Dividend Royal	2023-11-20	Monthly	12	10.77%	8.50
QYLD	Dividend Royal	2023-11-20	Monthly	11	7.50%	8.50
GAIN	Dividend Royal	2023-12-04	Monthly	20	8.19%	8.50
HRZN	Dividend King	2023-12-18	Monthly	15	6.60%	8.45
USOI	Dividend Royal	2023-11-20	Monthly	8	16.70%	8.28
PFLT	Dividend King	2023-11-15	Monthly	14	6.50%	8.27

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0151	1.500	9.70	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0152	1.200	9.49	10.00	[0 - 0.3]
returnOnEquityTTM	0.0539	1.500	-0.512	-0.768	[0.1 - 1]
payoutRatioTTM	1.312	-1.000	10.00	-10.00	[0 - 1]
currentRatioTTM	3.12	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	1.295	0.800	7.09	5.67	[0.8 - 2.5]
cashRatioTTM	0.176	1.500	-0.135	-0.203	[0.2 - 2]
debtRatioTTM	0.527	-1.500	1.209	-1.813	[0 - 0.6]
interestCoverageTTM	2.55	1.000	-0.165	-0.165	[3 - 30]
operatingCashFlowPerShareTTM	1.833	2.00	9.39	10.00	[0 - 30]
freeCashFlowPerShareTTM	0.914	2.00	9.54	10.00	[0 - 20]
debtEquityRatioTTM	1.895	-1.500	2.42	-3.63	[0 - 2.5]
grossProfitMarginTTM	0.304	1.000	8.27	8.27	[0.2 - 0.8]
operatingProfitMarginTTM	0.0498	1.000	-1.005	-1.005	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.145	1.000	-0.307	-0.307	[0.2 - 2]
assetTurnoverTTM	1.010	0.800	6.60	5.28	[0.5 - 2]
Total Score				7.62

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	44.70	1.000	5.59	0	[1 - 100]
returnOnEquityTTM	0.0539	2.50	-0.329	-0.768	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.914	2.00	9.70	10.00	[0 - 30]
dividendYielPercentageTTM	2.94	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	1.833	2.00	9.39	10.00	[0 - 30]
payoutRatioTTM	1.312	1.500	10.00	-10.00	[0 - 1]
pegRatioTTM	-2.77	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0756	1.000	-0.610	0	[0.1 - 0.5]
Total Score				3.42

Phibro Animal Health Corp

Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for livestock primarily in the United States. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture. Its animal health products also comprise antibacterials that are biological or chemical products used in the animal health industry to treat or to prevent bacterial diseases; anticoccidials primarily used to prevent and control the disease coccidiosis in poultry and cattle; anthelmintics to treat infestations of parasitic intestinal worms; and anti-bloat treatment products for cattle to control bloat in animals grazing on legume or wheat-pasture. In addition, the company offers nutritional specialty products, which enhance nutrition to help improve health and performance; and vaccines to prevent diseases primarily for the poultry and swine markets. Further, it manufactures and markets formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds; and various specialty ingredients for use in the personal care, industrial chemical, and chemical catalyst industries. The company sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle integrators, as well as through commercial animal feed manufacturers, wholesalers, and distributors. It operates in the United States, Latin America, Canada, Europe, the Middle East, Africa, and the Asia Pacific. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was incorporated in 2014 and is headquartered in Teaneck, New Jersey.